KEAP1 and pachyonychia congenita: In a study by Swamynathan et al., they utilized an oral pro-oxidant against the KEAP1-NRF2 antioxidant system, successfully induced triaptosis in PC cells, thereby effectively inhibiting the progression of metastatic PC.